Ozempic shortage extends into new year – but it’s still earning big

Meanwhile semaglutide medication Wegovy - indicated purely for weight loss - is added to the ARTG The enduring drought of type-2 diabetes medication Ozempic, blamed on its being prescribed off-label for weight loss, is no closer to resolution with shortages “until early 2023”, according to revised information from the Therapeutic Goods Administration (TGA). Just a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 8 September 2022
Next Delivery app joins pharmacy home delivery fray